ACAD
USDACADIA Pharmaceuticals Inc. Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$22.550
最高
$23.120
最低
$22.440
交易量
2.09M
公司基本面
市值
3.8B
行業
生物科技
國家
United States
交易統計
平均交易量
2.22M
交易所
NMS
貨幣
USD
52週範圍
相關新聞
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) today announced that on July 2, 2025, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock
Oppenheimer Maintains Perform on ACADIA Pharmaceuticals, Raises Price Target to $22
Oppenheimer analyst Jay Olson maintains ACADIA Pharmaceuticals with a Perform and raises the price target from $19 to $22.
HC Wainwright & Co. Reiterates Buy on ACADIA Pharmaceuticals, Maintains $32 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates ACADIA Pharmaceuticals with a Buy and maintains $32 price target.
Needham Reiterates Buy on ACADIA Pharmaceuticals, Maintains $30 Price Target
Needham analyst Ami Fadia reiterates ACADIA Pharmaceuticals with a Buy and maintains $30 price target.
Acadia Pharmaceuticals Hosts Inaugural R&D Day Showcasing Pipeline and Long-Term Value Drivers
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) will host its inaugural 2025 R&D Day today to highlight its key pipeline programs and their potential to drive long-term growth. Across nine disclosed programs, the
RBC Capital Maintains Outperform on ACADIA Pharmaceuticals, Raises Price Target to $38
RBC Capital analyst Brian Abrahams maintains ACADIA Pharmaceuticals with a Outperform and raises the price target from $26 to $38.
